Is There a Medtronic Insulin Pump Class Action Lawsuit?

There is currently no nationwide Medtronic insulin pump class action lawsuit for U.S. personal injury claims involving allegedly defective MiniMed pumps.

Instead, plaintiffs are pursuing individual product liability lawsuits seeking damages for injuries allegedly caused by Series 600 insulin pumps with defective clear plastic retainer rings.

MiniMed’s current disclosures describe claims involving serious personal injuries, including allegations of a death caused by incorrect insulin delivery from affected pumps.

Medtronic issued an urgent field safety notification directing users to inspect the retainer rings on affected pumps, and patients with damaged, loose, or missing rings were advised to stop using the pump and obtain a replacement.

Patients who experienced injuries involving these medical products may pursue individual product liability claims without waiting for a class action to be created.

Separate proposed class actions involving Medtronic diabetes technology have raised privacy allegations involving improper data sharing with third parties, but those cases are distinct from the MiniMed personal injury litigation.

Is There a Medtronic Insulin Pump MDL?

There is currently no federal multidistrict litigation, or MDL, for Medtronic MiniMed insulin pump personal injury claims.

Most current Series 600 retainer-ring cases are individual lawsuits coordinated in Los Angeles County Superior Court, while additional cases are pending in federal court.

The absence of an MDL does not prevent an injured patient from filing an individual product liability lawsuit or seeking financial compensation.

People who believe a MiniMed pump caused a serious injury should act promptly because filing deadlines vary by state and important medical or device evidence may become more difficult to obtain over time.

Users should preserve available pump records, glucose readings, medical records, recall correspondence, and other documentation concerning any health issues associated with the device.

TorHoerman Law reviews potential Medtronic MiniMed claims on a contingency fee basis, meaning clients do not pay attorney fees unless compensation is recovered.

What Is the Difference Between an MDL and a Class Action Lawsuit?

An MDL and a class action can both involve many people with similar allegations, but they operate differently.

In an MDL, individual lawsuits filed in federal courts may be transferred to one judge for coordinated pretrial proceedings involving common factual issues.

Each plaintiff generally keeps a separate lawsuit and must establish their own injuries, medical expenses, lost income, emotional distress, and other damages.

A class action instead allows one or more representative plaintiffs to pursue claims on behalf of a defined group that meets the requirements of Federal Rule of Civil Procedure 23.

Class members may be affected by the outcome of the case based on the terms of the certified class. MDLs may involve shared discovery, expert issues, motions, and sometimes bellwether trials, while unresolved cases can later return to their original courts for trial.

The current Medtronic MiniMed personal injury litigation is not proceeding as either a federal MDL or a nationwide U.S. class action.

Current U.S. Medtronic MiniMed lawsuits are primarily proceeding through coordinated state-court litigation rather than a federal MDL or nationwide personal injury class action.

The Medtronic MiniMed lawsuit litigation involves Series 600 insulin pumps with allegedly defective clear retainer rings that plaintiffs claim caused incorrect insulin delivery and serious injuries.

As of 2026, MiniMed reported more than 25 U.S. lawsuits involving more than 100 individuals.

Twenty-six of those lawsuits are coordinated in California State Court in Los Angeles County, while one case is pending in federal court in Washington and another is pending in federal court in New York.

This coordination allows common factual and legal issues involving the Series 600 pumps to be addressed together while individual plaintiffs continue to pursue their own injuries and damages.

Most U.S. Retainer Ring Cases Are Coordinated in California State Court

The California proceedings primarily involve allegations that a faulty retainer ring in certain MiniMed 630G and 670G pumps prevented the insulin reservoir from remaining securely locked inside the device.

Plaintiffs claim that movement of the reservoir or insulin cartridge could cause too much or too little insulin to be delivered.

FDA records confirm that the recall involved Series 600 pumps with the clear retainer ring design and that a broken or missing ring could result in insulin over-delivery or under-delivery.

The FDA identified device design as the cause of the recall. Pumps equipped with the redesigned black retainer ring were excluded from the original affected population.

Although many cases share allegations involving the same retainer-ring defect, each plaintiff must still establish the alleged malfunction, causation, injuries, and individual damages.

Thousands of Additional Potential Claims Have Been Identified

The number of filed Medtronic MiniMed lawsuits does not represent everyone who may be considering a claim.

Plaintiffs’ firms have notified MiniMed that they may pursue similar claims on behalf of approximately 2,000 additional individuals.

Many of these potential claims are subject to tolling arrangements that may temporarily preserve certain legal rights while the parties evaluate the litigation.

These individuals should not be counted as plaintiffs in filed lawsuits unless their claims are formally brought.

MiniMed has also disclosed that some potential claimants may become subject to a master settlement agreement, although no global settlement resolving all MiniMed insulin pump claims has been announced.

The distinction between filed cases and potential claims is important when evaluating the current size and status of the litigation.

What Is the Canadian Medtronic MiniMed Class Action Lawsuit?

A separate proposed class action involving Medtronic MiniMed Series 600 insulin pumps was filed in Ontario Superior Court in Canada in 2021.

MiniMed states that the Canadian case involves allegations similar to the U.S. lawsuits concerning allegedly defective clear retainer rings and remains in its early stages as of 2026.

The Canadian proceeding is separate from the U.S. litigation and does not mean that a nationwide Medtronic MiniMed personal injury class action has been created in the United States.

U.S. claims involving the retainer-ring defect continue to proceed primarily through individual lawsuits, with most filed cases coordinated in California state court.

The central U.S. personal injury litigation involves allegations that certain MiniMed Series 600 insulin pumps contained defective clear retainer rings.

Plaintiffs allege that the faulty ring could prevent the insulin reservoir from remaining securely locked inside the pump, causing the device to deliver too much or too little insulin.

MiniMed’s current SEC disclosures describe lawsuits seeking damages for alleged personal injuries, including deaths, associated with the Series 600 pumps and retainer-ring problem.

Individual lawsuits have included allegations of negligence and product liability, and some plaintiffs claim Medtronic failed to adequately warn patients about known or suspected defects.

The specific claims available in any case depend on the alleged defect, injury, applicable state law, federal medical-device law, and available evidence.

Medtronic has also faced separate legal actions involving privacy allegations and connected diabetes technology, but those cases are distinct from the product liability claims involving physical injuries allegedly caused by defective pumps.

Clear Retainer Ring Defects and Incorrect Insulin Delivery

The clear retainer ring is designed to secure the insulin reservoir inside certain MiniMed 600 Series pumps.

FDA records state that a broken or missing ring may prevent the reservoir from locking properly, which can result in the over-delivery or under-delivery of insulin.

Too much insulin can cause dangerously low blood sugar levels and severe hypoglycemia, while too little insulin can cause severe hyperglycemia and diabetic ketoacidosis, a medical emergency.

These complications can lead to loss of consciousness, seizures, metabolic abnormalities, coma, or even death.

In February 2020, the FDA classified the MiniMed recall as Class I after determining there was a reasonable probability that use of affected pumps could cause serious adverse health consequences or death.

The recall initially involved approximately 322,000 MiniMed 630G and 670G pumps distributed in the United States.

FDA later reported that Medtronic had been investigating an increase in complaints involving damaged clear retainer rings since June 2016 and criticized aspects of the company’s risk assessment and corrective-action procedures.

Plaintiffs rely on the device history, regulatory record, medical evidence, and circumstances of their individual injuries when alleging that the retainer-ring defect caused or contributed to their harm.

Yes. A multi-plaintiff MiniMed retainer-ring trial began in Los Angeles County Superior Court on May 11, 2026, and the jury returned its verdict on June 17, 2026.

The jury awarded no damages to three plaintiffs and found liability on certain claims involving a fourth pump user, awarding approximately $253,000 before a reduction of roughly one-third based on findings of proportionate responsibility.

The court entered judgment on the verdict in August 2026, although post-trial motions and a possible appeal may still follow.

The result provides an early jury outcome in the ongoing MiniMed litigation but does not determine the value or outcome of other pending or future claims.

2026 California MiniMed Retainer Ring Trial and Verdict

A multi-plaintiff trial involving MiniMed Series 600 insulin pumps began in Los Angeles County Superior Court on May 11, 2026.

The case involved four plaintiffs and allegations that defective clear retainer rings allowed insulin reservoirs to become unsecured, resulting in incorrect insulin delivery.

On June 17, 2026, the jury awarded no damages to three plaintiffs, including two pump users and one loss-of-consortium plaintiff.

The jury found liability on certain claims involving the remaining pump user and awarded approximately $253,000 in damages.

That award was later reduced by approximately one-third based on findings of proportionate responsibility.

The court entered judgment on the verdict in August 2026.

MiniMed has stated that the parties may still pursue post-trial motions and that any appeal would follow those proceedings.

The verdict represents an early trial result in the broader MiniMed retainer-ring litigation but does not establish the value or likely outcome of other pending claims.

You may qualify to file a Medtronic insulin pump lawsuit if you used an affected MiniMed Series 600 pump and suffered a serious injury after an alleged insulin delivery failure.

Current claims primarily involve MiniMed 630G and 670G pumps with allegedly defective clear retainer rings that may have allowed the insulin reservoir to become loose or improperly secured.

Plaintiffs allege that this defect could cause the pump to deliver too much insulin, too little insulin, or interrupt insulin delivery altogether.

Potentially qualifying injuries may include severe hypoglycemia, severe hyperglycemia, diabetic ketoacidosis, seizures, loss of consciousness, coma, hospitalization, permanent injury, or death.

A stronger potential claim generally includes medical records, pump data, glucose readings, photographs, replacement records, or other evidence connecting the alleged malfunction to the medical emergency.

The specific pump model, the nature of the alleged defect, the severity of the injury, and the timing of the event can all affect whether a claim may be viable.

Using a recalled MiniMed pump alone does not automatically establish eligibility for compensation.

TorHoerman Law can review the device information, medical evidence, and circumstances of the injury to determine whether you may qualify to pursue an individual Medtronic insulin pump lawsuit.

TorHoerman Law is reviewing claims involving Medtronic MiniMed insulin pumps and serious injuries allegedly caused by incorrect or interrupted insulin delivery.

Current litigation primarily involves MiniMed Series 600 pumps with allegedly defective clear retainer rings that may allow the insulin reservoir to become unsecured.

Potential claims may involve severe hypoglycemia, hyperglycemia, diabetic ketoacidosis, seizures, loss of consciousness, coma, hospitalization, permanent injury, or wrongful death.

TorHoerman Law can review the pump model, device records, blood glucose history, medical treatment, and other evidence to determine whether a potential claim may be supported.

The absence of a nationwide class action or federal MDL does not prevent an injured person from pursuing an individual lawsuit.

Filing deadlines vary by state, so potential claimants should avoid unnecessary delays when investigating their legal options.

TorHoerman Law handles these claims on a contingency fee basis, meaning there are no upfront attorney fees to begin a case.

If you or a loved one suffered severe hypoglycemia, hyperglycemia, diabetic ketoacidosis, seizure, diabetic coma, hospitalization, or wrongful death after an alleged Medtronic MiniMed pump malfunction, contact TorHoerman Law for an initial consultation.

Our dedicated team handles defective medical device claims on a contingency fee basis, meaning you do not pay attorney fees unless compensation is recovered for you.

You can also use the chat feature on this page to find out whether you may qualify to pursue a Medtronic MiniMed insulin pump claim.